BioSelective Capital Investments Acquires BioDuro's Irvine Drug Product Operations to Form Forma Life Sciences
February 4, 2026
BioSelective Capital Investments, together with Shayan Enterprises, LLC, acquired BioDuro’s drug product development and manufacturing operations in Irvine, California and formed Forma Life Sciences, Inc. The transaction transfers two U.S.-based oral solid dosage development and manufacturing facilities (≈65,000 sq ft and ≈40,000 sq ft) to the new Delaware-held company; BioDuro (an Advent portfolio company) sold the assets.
- Buyers
- BioSelective Capital Investments, Shayan Enterprises, LLC
- Targets
- BioDuro's Irvine drug product development and manufacturing operations (now Forma Life Sciences, Inc.)
- Sellers
- BioDuro, Advent International
- Industry
- Pharmaceuticals
- Location
- California, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.